Início › Câncer de Bexiga › Pensilvânia
Ensaios clínicos de Câncer de Bexiga em Pensilvânia
27 estudos para Câncer de Bexiga estão buscando participantes em locais em Pensilvânia.
Cidades em Pensilvânia
Texto oficial do estudo (Inglês)
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- Geisinger Medical Oncology-Lewisburg, Lewisburg
- e mais 3
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07000084Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- e mais 7
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Christiana Care Health System-Concord Health Center, Chadds Ford
- Geisinger Medical Center, Danville
- Geisinger Cancer Center Dickson City, Dickson City
- e mais 17
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06770582A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- MidLantic Urology ( Site 0102), Bala-Cynwyd
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06833073Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Pocono Medical Center, East Stroudsburg
- e mais 8
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT03866382A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Sidney Kimmel Comprehensive Cancer Center Thomas Jefferson University, Philadelphia
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07277413DESTINY-PANTUMOUR04
- Research Site, Philadelphia
RecrutandoEstudo observacional
Idades de 18 a 130 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
- AHN Allegheny General Hospital, Pittsburgh
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07218380Prehabilitation in High-risk Oncologic Surgery
- Fox Chase Cancer Center - Philadelphia, Philadelphia
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT07638410A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07217171ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of Pennsylvania, Philadelphia
- WellSpan Medical Oncology & Hematology at York Cancer Center, York
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT05059444Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Midlantic Urology (Solaris), Bala-Cynwyd
- Penn State University Milton S. Hershey Medical Center, Hershey
- Keystone Urology Specialists, Lancaster
- e mais 1
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06567743Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- University of Pittsburgh Medical Center, Pittsburgh
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 24 de ago. de 2026 · NCT05951179FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Penn Medicine Lancaster General Hospital - Ann B. Barshinger Cancer Institute, Lancaster
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
- e mais 2
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 20 de ago. de 2026 · NCT05614739Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Christiana Care Health System-Concord Health Center, Chadds Ford
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07097142LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT04752722A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Thomas Jefferson University, Philadelphia
RecrutandoFase 2
Idades 8 e acima · Todos os sexos · Atualizado em 27 de jul. de 2026 · NCT05503797Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- Penn State Medical Center, Urology Research, Hershey
Recrutando
Idades de 18 a 88 · Todos os sexos · Atualizado em 2 de jul. de 2026 · NCT06394869Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer
- University of Pennsylvania, Philadelphia
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 14 de mai. de 2026 · NCT06586255Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
- Abramson Cancer Center, Philadelphia
Recrutando
Idades 18 e acima · Todos os sexos · Atualizado em 13 de mai. de 2026 · NCT07048496The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Allegheny Health Network, Pittsburgh
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 5 de mar. de 2026 · NCT04075305Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- University of Pennsylvania, Philadelphia
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 18 de fev. de 2026 · NCT07030257Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Einstein Philadelphia Hospital, Philadelphia
Recrutando
Idades de 18 a 85 · Todos os sexos · Atualizado em 17 de fev. de 2026 · NCT07234968A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2026 · NCT06778863Virtual Histology of the Bladder Wall for Bladder Cancer Staging
- UPMC Hillman Cancer Center - Dept of Urology, Pittsburgh
RecrutandoFase 1 inicial
Idades de 18 a 90 · Todos os sexos · Atualizado em 17 de dez. de 2025 · NCT04369560SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.